Replication in Vitro

In a systematic study, the relationship between structure acquisition and self-assembly in NM fibrillization reactions was monitored through a series of biochemical and microscopic probes (Fig. 2) (Serio et al., 2000). Under these conditions, the conformational transition could not be temporally separated from self-assembly of NM. That is, the protein adopts the /1-rich structure as it assembles into fibers. The concentration dependences of the lag and assembly phases were also assessed in this study as an indirect measure of the relationship between conformational conversion and self-association. The results were consistent with a /1-rich structure s being conferred to protein concomitant with assembly (Serio et al., 2000 DePace et al., 1998). 

When freshly diluted protein or protein that had been incubated in physiologic buffer for a period of time was added to a small amount of preformed fibers, preincubated NM assembled at a rate 40-fold faster than freshly diluted NM. These results together indicate that an intermediate on pathway for both nucleation and assembly forms during the lag phase (Serio et al., 2000). 

These observations were inconsistent with some aspect of each of the models previously proposed for amyloid hbrillogenesis (Serio et al., 2000). Thus, a new model, nucleated conformational conversion, was proposed (Serio et al., 2000). According to this model, fibers arise de novo from nuclei formed during the lag phase. These nuclei are structured, stable complexes of NM formed when structurally molten, oligomeric complexes undergo a conformational rearrangement during the lag 

Such structurally fluid oligomeric complexes may act to partially restrict the conformational space available to a random coil peptide (Dill, 

It will be of great interest to determine how evolutionary pressures have honed the nature of the proteins assembly processes. In some cases, these may lead to separate pathways of amyloid formation in others, to similar pathways with different rate-limiting steps. 

---

DJ, Flores OA (2003) Characterization of resistance to non-obligate chain-terminating ribonu-cleoside analogs that inhibit hepatitis C virus replication in vitro. J Biol Chem 278 49164-49170... 

Warner N, Locamini S, Kuiper M, Bartholomeusz A, Ayres A, Yuen L, Shaw T (2007) The L80I substitution in the reverse transcriptase domain of the hepatitis B virus polymerase is associated with lamivudine resistance and enhanced viral replication in vitro, Antimicrob Agents Chemother 51 2285-2292... 

Balzarini J, Neyts J, Schols D, Hosoya M, Van Damme E, Peumans W, De Clercq E. The mannose-specific plant lectins from Cymbidium hybrid and Epipactis helleborine and the (TV-acetylglucosamine)w-specific plant lectin from Urtica dioica are potent and selective inhibitors of human immunodeficiency virus and cytomegalovirus replication in vitro. Antiviral Res 1992 18 191-207. 

H, Janssen MAC, De Clercq E, Janssen PAJ. Potent and selective inhibition of HIV-1 replication in vitro by a novel series of TIBO derivatives. Nature... 

Schwartz CS, Snyder R, Kalf GF. 1985. The inhibition of mitochondrial DNA replication in vitro by the metabolites of benzene, hydroquinone and p-benzoquinone. Chem-Biol Interact 53 327-350. 

Smith S, Stillman B (1991) Stepwise assembly of chromatin during DNA replication in vitro. EMBO J 10 971-980... 

Schwendener RA, et al. New lipophilic acyl/alkyl dinucleoside phosphates as derivatives of 3 -azido-3 -deoxythymidine Inhibition of HIV-1 replication in vitro and antiviral activity against Rauscher leukemia virus infected mice with delayed treatment regimens. Antivir Res 1994 24 79. 

Past-active In some recent studies,... Cr + increased DNA polymerase processivity and decreased its fidelity during DNA replication in vitro (13-17). (Adapted from Plaper et ak, 2002)... 

The Cadet laboratory has prepared phosphoramidites of stereoisomers for 5, 8-cyclo-dA and 5, 8-cyclo-dG for incorporation into oligonucleotides. Primer extension assays using the mammalian replicative enzyme pol 8 demonstrated that 5, 8-cyclonucleosides block DNA replication in vitro and thus would be highly... 

Fletcher RS, Arion D, Borkow G, Wainberg MA, Dmitrienko GI, Pamiak MA. Synergistic inhibition of HIV-1 reverse transcriptase DNA polymerase activity and virus replication in vitro by combinations of carboxanilide nonnucleoside compounds. Biochemistry 1995 34 10106-10112. 

Chong K-T, Pagano PJ, Hinshaw RR. Bis(heteroacyl)piperazine reverse transcriptase inhibitor in combination with 3 -azido-3 -deoxythymidine or 2, 3 -dideoxycytidine synergistically inhibits human immunodeficiency virus type 1 replication in vitro. Antimicrob Agents Chemother 1994 38 288-293. 

Johnson VA, Walker BD, Barlow MA, Paradis TJ, Chou T-C, Hirsch MS. Synergistic inhibition of human immunodeficiency virus type 1 and type 2 replication in vitro by castanospermine and 3 -azido-3 -deoxythymidine. Antimicrob Agents Chemother 1989 33 53-57. 

The idea that an inhibitor that binds to a nonenzymatic, nonreceptor site of a virion could inhibit viral replication in vivo would a priori be considered to be an unlikely scenario by most in the field of stmcture-based design. If this idea were proposed knowing only the structure of the native vims (especially HRV14, which has a closed-pocket conformation) skepticism would abound. This type of project arose not from a stmcture-based approach, but from the tried-and-tme screening approach. The compounds were first shown to be effective in inhibiting viral replication in vitro [52]. This was followed by an experiment showing that these compounds could inhibit at least one enterovims in a mouse model [94]. 

Prelich, G, Kostura, M., Marshak, D R, Matthews, M B., and Stillman, B. (1987) The cell-cycle regulated proliferating cell nuclear antigen is required for SV40-DNA replication in vitro Nature 326,471-475... 

Pauwels R, Andries K, Desmyter J, Schols D, Kukla MJ, Breslin HJ, Raeymaeckers A, Van Gelder J, Woestenborghs R, Heykants J, Schellekens K, Janssen MAC, De Clercq E, Janssen PAJ (1990) Potent and Selective Inhibition of HIV-1 Replication in Vitro by a Novel Series of TIBO Derivatives. Nature 343 470... 

Block viral replication in vitro Block HIV-1 cell entry in vitro... 

Taylor, R.W., Chinnery, P.P., Turnbull, D M. and Lightowlers, R.N. (1997) Selective inhibition of mutant human mitochondrial DNA replication in vitro by peptide nucleic acids. Nature Genetics, 15, 212-215. 

---